Skip to content

Our top five European small cap stocks for Q2


Carrying on in my series looking at the top small cap opportunities around the world, this week I'm looking at the European market (ex-UK).

I have been keeping track of the 15 stocks nominated from previous articles (US SmallCaps, Canadian SmallCaps, Asian SmallCaps), and as of 4 April, only three were down, with some considerable gains registered from other areas.

No less than three stocks were up over 12% in less than three weeks, including Canada's Tenaz Energy, which I looked at again in more detail last week.

1. Pharming [AMS:PHARM]

Pharming Group NV is listed on Euronext Amsterdam. The share price has not been doing well recently, so it should be approached with some degree of caution. Stock is trading at EUR 1.00 off a 52 week high of EUR 1.31. The healthcare stock issued some excellent financials for the quarter ending 31 December, with a net profit margin up 85%, net income up 78% and revenue up 48%. Pharming is a biopharma company which is engaged in developing and commercialising protein replacement therapies and precision medicines, with its drugs authorised for use in 30 markets.

2. Ascopiave Group [MIL:ASC]

We've seen some interesting price action from Italy's Ascopiave, although the stock is still down 14% over the last 52 weeks. That said, the shares are responding to some very positive numbers, with net profit margin up 154% and net income up 224%. Revenues are also up at +27%. Investors have responded to this, with the shares rallying off a recent low of EUR 1.97 to hit EUR 2.36 this morning. Ascopiave is involved in natural gas distribution for the Italian market, and certainly you could argue it has been hit by the lower gas prices we have been seeing in Europe last winter. The company has also diversified into renewable energy and water services.

Want the full story? Access all of The Armchair Trader's content for just £5.99 per month.

Get weekly investment ideas and tips that will take your investing to the next level. Sign up here.

Free 28 day trial. Cancel anytime.

Log In or Sign Up to Armchair Trader+

Already a member? Log in here:

Not a member yet? Sign up for your free trial or check out the benefits of membership.

Further content of this article is not available as it is for members only. Please visit the registration page for Armchair Trader Plus+ for further details on the benefits of becoming a member.

Looking for great investing ideas? Sign up to our free newsletter.

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
CME Group
Back To Top